These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Loss of disease tolerance during Citrobacter rodentium infection is associated with impaired epithelial differentiation and hyperactivation of T cell responses. Kang E; Zhou G; Yousefi M; Cayrol R; Xia J; Gruenheid S Sci Rep; 2018 Jan; 8(1):847. PubMed ID: 29339782 [TBL] [Abstract][Full Text] [Related]
5. Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing. Hoffmann C; Hill DA; Minkah N; Kirn T; Troy A; Artis D; Bushman F Infect Immun; 2009 Oct; 77(10):4668-78. PubMed ID: 19635824 [TBL] [Abstract][Full Text] [Related]
6. Indole-3-Carbinol Inhibits Wu Y; He Q; Yu L; Pham Q; Cheung L; Kim YS; Wang TTY; Smith AD Nutrients; 2020 Mar; 12(4):. PubMed ID: 32230738 [TBL] [Abstract][Full Text] [Related]
7. Wang J; Gao M; Wang J; Zeng Y; Wang C; Cao X Virulence; 2024 Dec; 15(1):2384553. PubMed ID: 39080852 [No Abstract] [Full Text] [Related]
8. Ovomucin and its hydrolysates differentially influenced colitis severity in Bao X; Ju T; Tollenaar S; Sergi C; Willing BP; Wu J Food Funct; 2024 Aug; 15(16):8496-8509. PubMed ID: 39056151 [TBL] [Abstract][Full Text] [Related]
9. Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis. Gonçalves NS; Ghaem-Maghami M; Monteleone G; Frankel G; Dougan G; Lewis DJ; Simmons CP; MacDonald TT Infect Immun; 2001 Nov; 69(11):6651-9. PubMed ID: 11598034 [TBL] [Abstract][Full Text] [Related]
10. Development of fatal colitis in FVB mice infected with Citrobacter rodentium. Borenshtein D; Nambiar PR; Groff EB; Fox JG; Schauer DB Infect Immun; 2007 Jul; 75(7):3271-81. PubMed ID: 17470543 [TBL] [Abstract][Full Text] [Related]
11. Citrobacter rodentium infection impairs dopamine metabolism and exacerbates the pathology of Parkinson's disease in mice. He Y; Zhao J; Ma Y; Yan X; Duan Y; Zhang X; Dong H; Fang R; Zhang Y; Li Q; Yang P; Yu M; Fei J; Huang F J Neuroinflammation; 2024 Jun; 21(1):153. PubMed ID: 38849869 [TBL] [Abstract][Full Text] [Related]
13. Myeloid deletion of talin-1 reduces mucosal macrophages and protects mice from colonic inflammation. Latour YL; McNamara KM; Allaman MM; Barry DP; Smith TM; Asim M; Williams KJ; Hawkins CV; Jacobse J; Goettel JA; Delgado AG; Piazuelo MB; Washington MK; Gobert AP; Wilson KT Sci Rep; 2023 Dec; 13(1):22368. PubMed ID: 38102166 [TBL] [Abstract][Full Text] [Related]
14. Lactobacillus rhamnosus GG coating with nanocomposite ameliorates intestinal inflammation. Zhai Z; Wang X; Qian Z; Wang A; Zhao W; Xiong J; Wang J; Wang Y; Cao H Biomed Pharmacother; 2024 Sep; 178():117197. PubMed ID: 39084077 [TBL] [Abstract][Full Text] [Related]
15. Oral delivery of sodium alginate/chitosan bilayer microgels loaded with Lactobacillus rhamnosus GG for targeted therapy of ulcerative colitis. Hu Y; Zhu S; Ye X; Wen Z; Fu H; Zhao J; Zhao M; Li X; Wang Y; Li X; Kang L; Aikemu A; Yang X Int J Biol Macromol; 2024 Aug; 278(Pt 3):134785. PubMed ID: 39153668 [TBL] [Abstract][Full Text] [Related]